Your browser is no longer supported. Please, upgrade your browser.
A [NYSE]
Agilent Technologies, Inc.
IndexS&P 500 P/E53.82 EPS (ttm)3.21 Insider Own0.30% Shs Outstand303.00M Perf Week-0.29%
Market Cap52.10B Forward P/E36.05 EPS next Y4.79 Insider Trans-13.00% Shs Float301.92M Perf Month1.29%
Income990.00M PEG1.01 EPS next Q1.17 Inst Own90.20% Short Float1.24% Perf Quarter17.80%
Sales6.14B P/S8.48 EPS this Y-31.60% Inst Trans0.96% Short Ratio2.15 Perf Half Y41.73%
Book/sh16.32 P/B10.59 EPS next Y11.16% ROA9.90% Target Price173.35 Perf Year78.28%
Cash/sh4.74 P/C36.49 EPS next 5Y53.30% ROE20.40% 52W Range95.44 - 179.57 Perf YTD45.81%
Dividend0.78 P/FCF50.29 EPS past 5Y12.00% ROI10.00% 52W High-3.79% Beta1.01
Dividend %0.45% Quick Ratio1.60 Sales past 5Y5.70% Gross Margin53.60% 52W Low81.02% ATR3.19
Employees16700 Current Ratio2.10 Sales Q/Q25.80% Oper. Margin20.40% RSI (14)56.15 Volatility1.72% 1.68%
OptionableYes Debt/Eq0.58 EPS Q/Q35.30% Profit Margin16.10% Rel Volume0.95 Prev Close172.44
ShortableYes LT Debt/Eq0.55 EarningsAug 17 AMC Payout23.10% Avg Volume1.74M Price172.77
Recom2.00 SMA20-1.20% SMA505.72% SMA20025.15% Volume1,654,791 Change0.19%
Mar-18-21Upgrade Citigroup Neutral → Buy $135 → $150
Feb-17-21Upgrade BofA Securities Neutral → Buy $147
Dec-02-20Initiated Goldman Buy $130
Nov-25-20Upgrade UBS Neutral → Buy $103 → $132
Nov-17-20Upgrade Cleveland Research Neutral → Buy
Nov-10-20Initiated KeyBanc Capital Markets Overweight $130
Sep-30-20Initiated Atlantic Equities Neutral $105
Aug-19-20Reiterated Wells Fargo Overweight $100 → $105
Aug-19-20Reiterated SVB Leerink Outperform $95 → $100
Aug-19-20Reiterated Stifel Hold $85 → $100
Aug-19-20Reiterated Robert W. Baird Outperform $87 → $104
Aug-19-20Reiterated Jefferies Buy $95 → $110
Aug-19-20Reiterated Citigroup Neutral $85 → $100
Aug-19-20Reiterated BofA Securities Neutral $99 → $103
Feb-24-20Downgrade Needham Buy → Hold
Jan-08-20Initiated Wells Fargo Overweight $100
Jan-07-20Initiated Citigroup Neutral $85
Nov-26-19Reiterated Needham Buy $92 → $85
Nov-15-19Initiated Stifel Hold
Oct-18-19Downgrade UBS Buy → Neutral $82
Sep-23-21 04:05PM  
Sep-22-21 04:05PM  
03:55PM  
Sep-20-21 06:20AM  
Sep-17-21 09:15AM  
08:38AM  
Sep-16-21 11:30AM  
Sep-07-21 08:00AM  
Sep-03-21 12:07PM  
11:30AM  
Sep-02-21 08:00AM  
Sep-01-21 11:00AM  
09:30AM  
Aug-26-21 09:31AM  
Aug-24-21 06:29PM  
06:14PM  
11:44AM  
Aug-23-21 11:00AM  
Aug-19-21 08:00AM  
06:04AM  
Aug-18-21 11:01AM  
10:53AM  
12:30AM  
Aug-17-21 05:40PM  
05:25PM  
04:05PM  
Aug-16-21 10:52AM  
10:43AM  
09:45AM  
09:30AM  
Aug-14-21 09:15AM  
Aug-13-21 09:10AM  
08:33AM  
08:30AM  
Aug-12-21 09:55AM  
09:05AM  
Aug-11-21 09:15AM  
Aug-10-21 03:00PM  
11:58AM  
10:54AM  
Aug-09-21 12:35PM  
12:04PM  
11:19AM  
11:02AM  
11:01AM  
Aug-08-21 03:02AM  
Aug-06-21 01:14PM  
11:31AM  
11:11AM  
10:40AM  
10:33AM  
09:47AM  
05:28AM  
Aug-05-21 01:36PM  
11:59AM  
10:37AM  
10:16AM  
10:01AM  
Aug-04-21 11:00AM  
Aug-03-21 12:52PM  
12:44PM  
12:29PM  
12:10PM  
11:54AM  
11:53AM  
08:20AM  
Aug-02-21 12:54PM  
12:10PM  
12:00PM  
11:27AM  
10:08AM  
09:32AM  
08:50AM  
Jul-30-21 12:02PM  
11:45AM  
11:42AM  
11:05AM  
11:05AM  
10:27AM  
10:00AM  
09:30AM  
Jul-29-21 11:59AM  
11:53AM  
11:30AM  
Jul-28-21 09:37AM  
08:00AM  
Jul-27-21 11:36AM  
10:58AM  
08:00AM  
Jul-26-21 11:45AM  
11:37AM  
Jul-22-21 11:00AM  
Jul-21-21 10:44AM  
08:00AM  
Jul-20-21 12:34PM  
08:30AM  
Jul-19-21 09:00AM  
Jul-15-21 10:41AM  
Jul-13-21 09:00AM  
Jul-09-21 11:09AM  
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; inductively coupled plasma mass and optical emission spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate readers; laboratory software, information management, and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment to produce synthesized oligonucleotide. It also offers immunohistochemistry, in situ hybridization, and hematoxylin and eosin staining and special staining; instruments, consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. It has collaboration agreement with SGS AXYS. The company was incorporated in 1999 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grau DominiqueSenior Vice PresidentAug 18Option Exercise40.809,033368,54690,453Aug 20 11:28 AM
Grau DominiqueSenior Vice PresidentAug 18Sale165.069,0331,490,94281,420Aug 20 11:28 AM
Grau DominiqueSenior Vice PresidentAug 05Option Exercise40.809,033368,54690,453Aug 09 03:54 PM
Grau DominiqueSenior Vice PresidentAug 05Sale155.009,0331,400,11581,420Aug 09 03:54 PM
Grau DominiqueSenior Vice PresidentJun 17Option Exercise40.801,96880,29483,388Jun 21 05:18 PM
Grau DominiqueSenior Vice PresidentJun 17Sale145.101,968285,56381,420Jun 21 05:18 PM
Grau DominiqueSenior Vice PresidentJun 16Option Exercise40.803,487142,27084,907Jun 17 12:16 PM
Grau DominiqueSenior Vice PresidentJun 16Sale145.013,487505,65381,420Jun 17 12:16 PM
Grau DominiqueSenior Vice PresidentJun 15Option Exercise40.803,578145,98284,998Jun 17 12:16 PM
Grau DominiqueSenior Vice PresidentJun 15Sale145.033,578518,91781,420Jun 17 12:16 PM
Ancher-Jensen HenrikSr Vice PresidentJun 14Option Exercise40.8024,8411,013,513120,633Jun 17 12:13 PM
Ancher-Jensen HenrikSr Vice PresidentJun 14Sale143.6643,7316,282,52776,902Jun 17 12:13 PM
Thaysen JacobSr. Vice PresidentJun 10Sale142.9016,2892,327,69883,423Jun 14 12:18 PM
MCDONNELL PADRAIGSr. Vice PresidentMay 28Sale138.421,000138,42016,916Jun 01 06:19 PM
Tang MichaelSVP, General Counsel, and Sec.May 27Sale136.1513,4651,833,35139,579Jun 01 06:18 PM
Tang MichaelSVP, General Counsel, and Sec.Apr 23Sale137.0050068,50053,030Apr 26 05:59 PM
McMullen Michael R.CEO and PresidentApr 22Sale135.009,0531,222,155261,105Apr 26 05:58 PM
McMullen Michael R.CEO and PresidentApr 13Sale132.508,9661,187,995270,158Apr 15 06:47 PM
McMullen Michael R.CEO and PresidentApr 08Sale130.2615,0951,966,275279,124Apr 12 07:01 PM
Gonsalves RodneyV.P., Corporate ControllerFeb 22Sale124.175,000620,85041,229Feb 24 05:54 PM
Grau DominiqueSenior Vice PresidentFeb 17Option Exercise40.809,034368,58795,071Feb 18 06:31 PM
Tang MichaelSVP, General Counsel, and Sec.Feb 17Sale133.0050066,50053,530Feb 18 06:48 PM
Grau DominiqueSenior Vice PresidentFeb 17Sale135.1113,7451,857,08781,326Feb 18 06:31 PM
Tang MichaelSVP, General Counsel, and Sec.Feb 16Sale129.3150064,65554,030Feb 18 06:48 PM
McMullen Michael R.CEO and PresidentFeb 16Sale130.0020,7662,699,580294,219Feb 18 06:33 PM
Grau DominiqueSenior Vice PresidentFeb 16Sale130.146,041786,19486,037Feb 18 06:31 PM
McMullen Michael R.CEO and PresidentFeb 02Sale123.7441,9785,194,232314,985Feb 03 01:28 PM
McMullen Michael R.CEO and PresidentFeb 01Sale120.2621,2122,550,955356,963Feb 03 01:28 PM
Tang MichaelSVP, General Counsel, and Sec.Jan 14Sale127.2750063,63554,880Jan 19 05:01 PM
McMullen Michael R.CEO and PresidentDec 01Sale115.6385,8429,925,910415,347Dec 02 08:17 PM
KOH BOON HWEEDirectorNov 30Sale114.5120,0002,290,20068,051Dec 02 08:16 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 09Sale116.162,222258,10856,807Nov 12 01:31 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 05Sale111.001,111123,32159,029Nov 09 02:33 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 04Sale108.501,111120,54460,140Nov 05 03:45 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 03Sale106.431,111118,24461,251Nov 05 03:45 PM
Tang MichaelSVP, General Counsel, and Sec.Nov 02Sale103.521,111115,01162,362Nov 03 03:41 PM
Tang MichaelSVP, General Counsel, and Sec.Oct 30Sale101.773,333339,19963,473Nov 03 03:41 PM
Grau DominiqueSenior Vice PresidentOct 09Option Exercise39.126,485253,693104,154Oct 13 02:32 PM
Grau DominiqueSenior Vice PresidentOct 09Sale105.006,485680,92597,669Oct 13 02:32 PM